Literature DB >> 22537083

The rapidly emerging ESBL-producing Escherichia coli O25-ST131 clone carries LPS core synthesis genes of the K-12 type.

Valéria Szijártó1, Tibor Pal, Gabor Nagy, Eszter Nagy, Akela Ghazawi, Mohammed al-Haj, Sylvia El Kurdi, Agnes Sonnevend.   

Abstract

The clone Escherichia coli O25 ST131, typically producing extended-spectrum beta-lactamases (ESBLs), has spread globally and became the dominant type among extraintestinal isolates at many parts of the world. However, the reasons behind the emergence and success of this clone are only partially understood. We compared the core type genes by PCR of ESBL-producing and ESBL-nonproducing strains isolated from urinary tract infections in the United Arab Emirates and found a surprisingly high frequency of the K-12 core type (44.6%) among members of the former group, while in the latter one, it was as low (3.7%), as reported earlier. The high figure was almost entirely attributable to the presence of members of the clone O25 ST131 among ESBL producers. Strains from the same clone isolated in Europe also carried the K-12 core type genes. Sequencing the entire core operon of an O25 ST131 isolate revealed a high level of similarity to known K-12 core gene sequences and an almost complete identity with a recently sequenced non-O25 ST131 fecal isolate. The exact chemical structure and whether and how this unusual core type contributed to the sudden emergence of ST131 require further investigations.
© 2012 Federation of European Microbiological Societies. Published by Blackwell Publishing Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22537083     DOI: 10.1111/j.1574-6968.2012.02585.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  5 in total

Review 1.  Escherichia coli ST131, an intriguing clonal group.

Authors:  Marie-Hélène Nicolas-Chanoine; Xavier Bertrand; Jean-Yves Madec
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

2.  Diagnostic potential of monoclonal antibodies specific to the unique O-antigen of multidrug-resistant epidemic Escherichia coli clone ST131-O25b:H4.

Authors:  Valéria Szijártó; Jolanta Lukasiewicz; Tomasz K Gozdziewicz; Zoltán Magyarics; Eszter Nagy; Gábor Nagy
Journal:  Clin Vaccine Immunol       Date:  2014-04-30

3.  Bactericidal monoclonal antibodies specific to the lipopolysaccharide O antigen from multidrug-resistant Escherichia coli clone ST131-O25b:H4 elicit protection in mice.

Authors:  Valéria Szijártó; Luis M Guachalla; Zehra C Visram; Katharina Hartl; Cecília Varga; Irina Mirkina; Jakub Zmajkovic; Adriana Badarau; Gerhild Zauner; Clara Pleban; Zoltán Magyarics; Eszter Nagy; Gábor Nagy
Journal:  Antimicrob Agents Chemother       Date:  2015-03-16       Impact factor: 5.191

4.  A New Tool for Complement Research: In vitro Reconstituted Human Classical Complement Pathway.

Authors:  Michele Mutti; Katharina Ramoni; Gábor Nagy; Eszter Nagy; Valéria Szijártó
Journal:  Front Immunol       Date:  2018-12-04       Impact factor: 7.561

5.  Complete Genome Sequence of Escherichia coli 81009, a Representative of the Sequence Type 131 C1-M27 Clade with a Multidrug-Resistant Phenotype.

Authors:  Michele Mutti; Ágnes Sonnevend; Tibor Pál; Sini Junttila; Heinz Ekker; Bence Galik; Attila Gyenesei; Gábor Nagy; Eszter Nagy; Valéria Szijártó
Journal:  Genome Announc       Date:  2018-02-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.